BD SurePath™ liquid-based Pap test
BD SurePath™ liquid-based Pap test is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses*. BD SurePath™ liquid-based Pap test provides the following advantages over conventional Pap smears and other LBC (Liquid-Based Collection) tests resulting in grea…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
BD SurePath™ liquid-based Pap test is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses*.
BD SurePath™ liquid-based Pap test provides the following advantages over conventional Pap smears and other LBC (Liquid-Based Collection) tests resulting in greater disease detection.
BD SurePath™ test collection process allows the laboratory access for repeat testing from the residual cell solution, providing more effective patient management.
